Owner Aventis Pharma S.A.

Inventors Thurairatnam, Sukanthini; Wentzler, Sylvie; Aldous, David John; Ratcliffe, Andrew James; Nemecek, Conception; Majid, Tahir Nadeem; Souness, John Edward; Amendola, Shelly; Venot, Corinne; Walsh, Rodger John Aitchison

Agent Watermark

Pub. Number AU-B-2002337142

PCT Number PCT/EP02/11131

PCT Pub. Number WO2003/024967

Priority 60/355,860 11.02.02 US; 0122560.6 19.09.01 GB

Filing date 17 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 11 October 2007

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups